Howard Liang

Howard Liang currently works at BeiGene USA, Inc., as Treasurer & Director, BeiGene (Guangzhou) Co., Ltd., as Director from 2019, and BeiGene Pharmaceuticals (Guangzhou) Co. Ltd., as Director from 2019.
Dr. Liang also formerly worked at Leerink Partners LLC, as Managing Director from 2012 to 2015, Abbott Laboratories, as Senior Scientist, Prudential Securities, as Senior Analyst, A.G.
Edwards & Sons, Inc., as Vice President, Citizens JMP Securities LLC, as Principal, BeOne Medicines Ltd., as Chief Financial & Strategy Officer from 2015 to 2021, and Tessera Therapeutics, Inc., as President & Chief Financial Officer from 2021 to 2025.
Dr. Liang received his undergraduate degree from Peking University and Masters Business Admin degree and doctorate degree from The University of Chicago.